Opinion: Taxable Tuition = Trouble for Graduate Students

Our calculations find troubling increases in taxes if a US House–led tax plan succeeds, but tuition waivers, as the Senate bill has proposed, could actually reduce students’ tax burdens.

Written byPatricia M. Lawston and Michael T. Parker
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, WUTWHANFOTOFollowing the approval of a similar bill in the House earlier this month, the Senate Budget Committee approved a tax proposal Tuesday (November 28) that would have far-reaching effects on taxpayers across the country. As lawmakers continue deliberations, graduate students are becoming increasingly vocal with their concerns about how proposed changes within the Tax Cuts and Jobs Act (H.R. 1) will affect their lives.

These include changes to student loan interest rates, tuition reduction, and education assistance programs, consolidation of tax credits, and elimination of debt forgiveness for tragic life events. But as most students now know from their newsfeeds and social media networks, the elimination of tuition waivers under the House (but not the Senate) version of the plan, resulting in the treatment of these funds as taxable income, may be the most alarming adjustment.

Numerous articles have been published in the past few weeks with varying tenors on the topic, but the message has mostly been this: Students are in trouble. Just how much trouble, however, has been a little fuzzy. So, we set out to consider a variety of scenarios using real tuition and income to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies